Tag:
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- HTA in Medtech - Free SymposiumSaturday, June 2, 2012 — ISPOR Washington
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
Press Releases
- New York Genome Center Announces Formal Commencement of Collaborative Relationship with Illumina
- Baxano Completes Enrollment in Lumbar Spinal Stenosis Study
- PRA Expands Operations in Europe
- New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
- Greatbatch to Establish New Global Headquarters
- More Press Releases
Featured Jobs
-
Director, Regulatory Affairs
Tesaro - Waltham, MA -
Project Manager, Marketing Excellence Job
Celgene Corporation - Summit, NJ, US -
Director, Quality
Sucampo Pharmaceuticals - Washington, DC -
Oncology Knowledge Lead
Merck - Boston, MA -
Sr. Director, Healthcare Compliance Audit Job
Celgene Corporation - Summit, NJ, US
